M. A. Altinoz Et Al. , "HIGH DOSE PROGESTERONE INDUCES GROWTH INHIBITION IN HUMAN U87 AND A172 GLIOBLASTOMA CELL WITH CONCOMITANT CHANGES IN MITOCHONDRIAL AND CYTOSKELETON PROTEINS," 13th Meeting of the European-Association-of-Neurooncology (EANO) , vol.20, Stockholm, Sweden, pp.291-292, 2018
Altinoz, M. A. Et Al. 2018. HIGH DOSE PROGESTERONE INDUCES GROWTH INHIBITION IN HUMAN U87 AND A172 GLIOBLASTOMA CELL WITH CONCOMITANT CHANGES IN MITOCHONDRIAL AND CYTOSKELETON PROTEINS. 13th Meeting of the European-Association-of-Neurooncology (EANO) , (Stockholm, Sweden), 291-292.
Altinoz, M. A., Yilmaz, M., Ucal, Y., Ozpinar, A., Baskan, O., & Elmaci, I., (2018). HIGH DOSE PROGESTERONE INDUCES GROWTH INHIBITION IN HUMAN U87 AND A172 GLIOBLASTOMA CELL WITH CONCOMITANT CHANGES IN MITOCHONDRIAL AND CYTOSKELETON PROTEINS . 13th Meeting of the European-Association-of-Neurooncology (EANO) (pp.291-292). Stockholm, Sweden
Altinoz, M. Et Al. "HIGH DOSE PROGESTERONE INDUCES GROWTH INHIBITION IN HUMAN U87 AND A172 GLIOBLASTOMA CELL WITH CONCOMITANT CHANGES IN MITOCHONDRIAL AND CYTOSKELETON PROTEINS," 13th Meeting of the European-Association-of-Neurooncology (EANO), Stockholm, Sweden, 2018
Altinoz, M. A. Et Al. "HIGH DOSE PROGESTERONE INDUCES GROWTH INHIBITION IN HUMAN U87 AND A172 GLIOBLASTOMA CELL WITH CONCOMITANT CHANGES IN MITOCHONDRIAL AND CYTOSKELETON PROTEINS." 13th Meeting of the European-Association-of-Neurooncology (EANO) , Stockholm, Sweden, pp.291-292, 2018
Altinoz, M. A. Et Al. (2018) . "HIGH DOSE PROGESTERONE INDUCES GROWTH INHIBITION IN HUMAN U87 AND A172 GLIOBLASTOMA CELL WITH CONCOMITANT CHANGES IN MITOCHONDRIAL AND CYTOSKELETON PROTEINS." 13th Meeting of the European-Association-of-Neurooncology (EANO) , Stockholm, Sweden, pp.291-292.
@conferencepaper{conferencepaper, author={M. A. Altinoz Et Al. }, title={HIGH DOSE PROGESTERONE INDUCES GROWTH INHIBITION IN HUMAN U87 AND A172 GLIOBLASTOMA CELL WITH CONCOMITANT CHANGES IN MITOCHONDRIAL AND CYTOSKELETON PROTEINS}, congress name={13th Meeting of the European-Association-of-Neurooncology (EANO)}, city={Stockholm}, country={Sweden}, year={2018}, pages={291-292} }